Last reviewed · How we verify

NCT04180241: POEM

Development of Endoscopic Treatment for Achalasia

Active, enrolled NA Last updated 8 May 2024
What this trial tests

NA trial testing POEM in Achalasia in 55 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
15 April 2019
Primary endpoint
31 December 2026
31 December 2027

Quick facts

Lead sponsorKarolinska Institutet
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment55
Start date15 April 2019
Primary completion31 December 2026
Estimated completion31 December 2027
Sites2 locations across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Karolinska Institutet

Who can join

Adults 18 to 70, any sex, with Achalasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Per Oral Endoscopic Myotomy (POEM); comparison of two surgical techniques division all the esophageal muscle layers versus division the inner circular muscle layer of the esophagus only.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of POEM

Trials testing the same drug.

Other recruiting trials for Achalasia

Currently open trials in the same condition.

Other Karolinska Institutet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04180241.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing